New clotting drug and aspirin: safe together? early study seeks answers

NCT ID NCT07652723

Recruiting now Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This early-stage study tests whether a new drug (BAY3389934) for blood clotting problems in sepsis can be safely given with aspirin. Sixteen healthy adults will receive the drug alone, aspirin alone, and both together in random order. The goal is to check for side effects and see how the two drugs affect blood clotting. Participants will not benefit directly, but results will guide future use in sepsis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Pharmacology of Miami, LLC - Cardiology Department

    RECRUITING

    Miami, Florida, 33014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.